INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 21S · 3 late76 trades$25.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05CFCheng Chi Fung0B / 42S42 trades$15.33M
  6. 06RARothblatt Martine A0B / 33S33 trades$5.50M
  7. 07RJRubinstein Julie0B / 32S32 trades$5.55M
  8. 08LBLeach Bryan0B / 30S30 trades$7.97M
  9. 09AOAtay Oguzhan0B / 30S30 trades$7.55M
  10. 10JDJenkins William D Jr0B / 30S30 trades$13.38M

Form 4 transactions

66,723 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
269.3K sh
Oct 28, 2026Oct 30, 2026
Page 113 of 1669
← PrevNext →
traded Oct 28, 2026
+2d
SEC Form 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
195.0K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
HD
Hutcheson Stewart DDirector
IDCCInterDigital, Inc.
Grant or award
A—
47 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
87.7K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
48.0K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
JJ
Jacobs Kevin JSee Remarks
HLTHilton Worldwide Holdings Inc.
Option exercise
M—
31.1K sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

9
WM
Wunsch Scott MCEO, Logistics
SRTAStrata Critical Medical, Inc.
Grant or award
A—
1,416 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
82.5K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
87.7K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
JJ
Jacobs Kevin JSee Remarks
HLTHilton Worldwide Holdings Inc.
Option exercise
M—
29.1K sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
368.3K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
RF
Rankin Jean FDirector
IDCCInterDigital, Inc.
Grant or award
A—
2 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
824.0K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
JJ
Jacobs Kevin JSee Remarks
HLTHilton Worldwide Holdings Inc.
Option exercise
M—
16.0K sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

9
JJ
Jacobs Kevin JSee Remarks
HLTHilton Worldwide Holdings Inc.
Option exercise
M—
28.5K sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

9
MD
Markley John D. Jr.Director
IDCCInterDigital, Inc.
Grant or award
A—
8 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
WL
West Michael LCEO - Moody's Ratings
MCOMOODYS CORP /DE/
Option exercise
M—
6,820 sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
682.9K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
HT
Hoffmann Michael ThomasEVP & General Counsel
NXPINXP Semiconductors N.V.
Grant or award
A—
1,788 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
SR
Sotomayor RafaelCEO & President
NXPINXP Semiconductors N.V.
Grant or award
A—
20.3K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
126.2K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
36.1K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
AK
Aberle Derek KDirector
IDCCInterDigital, Inc.
Grant or award
A—
2 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
269.3K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
CP
Carey Stephen P.SVP & CFO
ANIPANI PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$208K
2,850 sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
82.5K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
VG
vant Hoff GrahamDirector
ANNAAleAnna, Inc.
Option exercise
M—
20.2K sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
65.0K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
133.1K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
824.0K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

7
LA
Le-Quoc AlexisDirector, Chief Technology Officer
DDOGDatadog, Inc.
Open-market sale · 10b5-1 plan
SELL$3.17M
11.4K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

7
LA
Le-Quoc AlexisDirector, Chief Technology Officer
DDOGDatadog, Inc.
Open-market sale · 10b5-1 plan
SELL$2.87M
10.3K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

7
LA
Le-Quoc AlexisDirector, Chief Technology Officer
DDOGDatadog, Inc.
Open-market sale · 10b5-1 plan
SELL$1.57M
5,670 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

6
JW
Juvenal Tobin WChief Commercial Officer
CSTLCASTLE BIOSCIENCES INC
Open-market sale · 10b5-1 plan
SELL$44K
1,237 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

5
CL
Chen Lawrence LirenDirector, President and CEO
IDCCInterDigital, Inc.
Grant or award
A—
68 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

5
PR
Pankaj RajeshChief Technology Officer
IDCCInterDigital, Inc.
Grant or award
A—
34 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

5
JL
Jensen Christopher LEVP, Chief People Officer
NXPINXP Semiconductors N.V.
Grant or award
A—
4,291 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

5
RD
Ruppel DavidSVP & GM Transportation Bus.
LFUSLITTELFUSE INC /DE
Option exercise
M—
1,112 sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

5
BW
Betz WilliamEVP & CFO
NXPINXP Semiconductors N.V.
Grant or award
A—
5,364 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

5
HA
Hardy AndrewEVP, Chief Sales Officer
NXPINXP Semiconductors N.V.
Grant or award
A—
3,576 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
  3. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  4. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  5. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  6. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K